← Open Payments lookup

JULIE SEAMAN: Open Payments

NPI 1548936917 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$696 in 26 payments from 12 companies in 2025. Trend: 2023 $513 · 2024 $735 · 2025 $696

Food & beverage: $696
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$154
Vanda Pharmaceuticals Inc.4$124
ABBVIE INC.5$99
Alkermes, Inc.3$72
Teva Pharmaceuticals USA, Inc.3$52
Janssen Pharmaceuticals, Inc1$43
Tris Pharma Inc2$36
E.R. Squibb & Sons, L.L.C.1$30
Neurocrine BioSciences, Inc.1$23
TMS NeuroHealth Centers Inc.1$22

Products named: ABILIFY MAINTENA, HETLIOZ, VRAYLAR, ARISTADA, INVEGA SUSTENNA, Dyanavel XR, AUSTEDO XR, COBENFY.

Industry payments across MD — which companies pay providers there.